Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 19025220)

1.

Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease.

Furr AE, Ranganathan S, Finn OJ.

Pediatr Dev Pathol. 2010 Jan-Feb;13(1):24-31. doi: 10.2350/08-06-0479.1.

PMID:
19025220
2.
3.

Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ.

Pancreas. 2010 May;39(4):510-5. doi: 10.1097/MPA.0b013e3181bd6501.

4.

Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Reddy KP, Markowitz JE, Ruchelli ED, Baldassano RN, Brown KA.

Dig Dis Sci. 2007 Feb;52(2):365-72. Epub 2007 Jan 12.

PMID:
17219072
5.

Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children.

Shaoul R, Okada Y, Cutz E, Marcon MA.

J Pediatr Gastroenterol Nutr. 2004 May;38(5):488-93.

PMID:
15097436
6.

Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.

Beatty PL, Narayanan S, Gariépy J, Ranganathan S, Finn OJ.

Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194. Epub 2010 Mar 23.

7.

Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.

Hosokawa T, Kusugami K, Ina K, Ando T, Shinoda M, Imada A, Ohsuga M, Sakai T, Matsuura T, Ito K, Kaneshiro K.

J Gastroenterol Hepatol. 1999 Oct;14(10):987-96.

PMID:
10530495
8.

Immunoreactivity against Goblet cells in patients with inflammatory bowel disease.

Ardesjö B, Portela-Gomes GM, Rorsman F, Gerdin E, Lööf L, Grimelius L, Kämpe O, Ekwall O.

Inflamm Bowel Dis. 2008 May;14(5):652-61. doi: 10.1002/ibd.20370.

PMID:
18213698
9.

Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS.

Cancer Res. 1993 Feb 1;53(3):641-51.

10.

Increased expression of IL-16 in inflammatory bowel disease.

Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S.

Gut. 2001 Mar;48(3):326-32.

11.

[Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].

Papp M.

Orv Hetil. 2008 Nov 30;149(48):2269-76. doi: 10.1556/OH.2008.28463. Hungarian.

PMID:
19028649
13.

Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.

Ho SB, Ewing SL, Montgomery CK, Kim YS.

Oncol Res. 1996;8(2):53-61.

PMID:
8859775
14.

Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases.

Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, Lehr HA, Schmidt J, Neurath MF.

Am J Gastroenterol. 2005 Jan;100(1):64-72.

PMID:
15654782
15.

Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.

Souza HS, Tortori CJ, Castelo-Branco MT, Carvalho AT, Margallo VS, Delgado CF, Dines I, Elia CC.

Int J Colorectal Dis. 2005 May;20(3):277-86. Epub 2004 Oct 22.

PMID:
15503066
16.

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF.

Dig Dis Sci. 1995 Mar;40(3):485-94.

PMID:
7895532
17.

Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.

Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF.

Dig Dis Sci. 1996 Apr;41(4):660-9.

PMID:
8674385
18.
19.

Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.

Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A.

Int J Gastrointest Cancer. 2005;36(1):39-46.

PMID:
16227634
20.

O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.

Premaratne P, Welén K, Damber JE, Hansson GC, Bäckström M.

Tumour Biol. 2011 Feb;32(1):203-13. doi: 10.1007/s13277-010-0114-9. Epub 2010 Sep 26.

PMID:
20872286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk